![Figure 9: Effect of GFH009 treatment on CDK9-dependent protein expression in vivo.](https://www.oncotarget.net/wp-content/uploads/2023/12/Screen-Shot-2023-12-27-at-1.23.18-PM-300x217.png)
GFH009: A Potent and Highly Selective CDK9 Inhibitor for the Treatment of Hematologic Malignancies
December 27, 2023
the results of this preclinical investigation program suggest that induction of apoptosis is a key component of GFH009’s anti-tumor mechanism of action [...]”BUFFALO, NY- December 27, 2023 – A new... read more